Wellington Management Group
LOXO

Wellington Management Group’s Loxo Oncology, Inc LOXO Stock Holding History

Wellington Management Group’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,793,587
Closed -$251M – 2187
2018
Q4 		$251M Sell
1,793,587
-19,224
-1% -$2.92M 0.06% 286
2018
Q3 		$310M Sell
1,812,811
-11,172
-0.6% -$1.88M 0.07% 290
2018
Q2 		$316M Sell
1,823,983
-141,953
-7% -$21.3M 0.07% 284
2018
Q1 		$227M Sell
1,965,936
-126,215
-6% -$13.4M 0.05% 348
2017
Q4 		$176M Sell
2,092,151
-385,979
-16% -$32.2M 0.04% 395
2017
Q3 		$228M Buy
2,478,130
+28,365
+1% +$2.2M 0.05% 319
2017
Q2 		$196M Buy
2,449,765
+11,893
+0.5% +$659K 0.05% 337
2017
Q1 		$103M Buy
2,437,872
+623,730
+34% +$25.7M 0.02% 503
2016
Q4 		$58.3M Buy
1,814,142
+212,608
+13% +$5.45M 0.01% 673
2016
Q3 		$41.9M Buy
1,601,534
+313,428
+24% +$8.2M 0.01% 747
2016
Q2 		$29.9M Buy
1,288,106
+793,674
+161% +$19.8M 0.01% 818
2016
Q1 		$13.5M Buy
+494,432
New +$10.3M ﹤0.01% 1053

Other funds holding LOXO

IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $5.27B AUM 41.17% 1-Year Est. Return

Wellington Management Group's LOXO Position: Q1 2019 in Review

Wellington Management Group sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 1,793,587 shares — an estimated $251M sold.

Wellington Management Group first reported a position in LOXO in Q1 2016 and held it in 12 quarters. The position peaked at $316M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Wellington Management Group reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Wellington Management Group sold 1,793,587 Loxo Oncology, Inc shares in Q1 2019, an estimated $251M.
  • Wellington Management Group first reported a position in Loxo Oncology, Inc in Q1 2016 and held it in 12 quarters.
  • Wellington Management Group's Loxo Oncology, Inc position peaked at $316M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Wellington Management Group's 13F filing for Q1 2019, filed 15 May 2019.